Cargando…
Blood and Cerebrospinal Fluid Biomarkers of Inflammation in Parkinson’s Disease
Given the clear role of inflammation in the pathogenesis of Parkinson’s disease (PD) and its impact on incidence and phenotypical characteristics, this review provides an overview with focus on inflammatory biofluid markers in blood and cerebrospinal fluid (CSF) in PD patient cohorts. In preparation...
Autores principales: | Zimmermann, Milan, Brockmann, Kathrin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9535573/ https://www.ncbi.nlm.nih.gov/pubmed/35661021 http://dx.doi.org/10.3233/JPD-223277 |
Ejemplares similares
-
Longitudinal Measurements of Cerebrospinal Fluid Biomarkers in Parkinson's Disease
por: Hall, Sara, et al.
Publicado: (2016) -
Latest advances in cerebrospinal fluid and blood biomarkers of
Alzheimer’s disease
por: Milà-Alomà, Marta, et al.
Publicado: (2019) -
Diagnostic cerebrospinal fluid biomarkers for Parkinson's disease: A pathogenetically based approach
por: van Dijk, Karin D., et al.
Publicado: (2010) -
Evolution of Alzheimer's Disease Cerebrospinal Fluid Biomarkers in Early Parkinson's Disease
por: Irwin, David J., et al.
Publicado: (2020) -
What is the Clinical Significance of Cerebrospinal Fluid Biomarkers in Parkinson's disease? Is the Significance Diagnostic or Prognostic?
por: Kim, Dana, et al.
Publicado: (2014)